Description
Additional file 2: Supplementary Table 2. Risks and events by year with amide I maximum ≥1644 cm− 1,
| Date made available | 1 Jan 2020 |
|---|---|
| Publisher | Unknown Publisher |
Additional file 2 of Amyloid-β misfolding as a plasma biomarker indicates risk for future clinical Alzheimer’s disease in individuals with subjective cognitive decline
- Julia Stockmann (Contributor)
- Inge M.W. Verberk (Contributor)
- Nina Timmesfeld (Contributor)
- Robin Denz (Contributor)
- Brian Budde (Contributor)
- Julia Lange-Leifhelm (Contributor)
- Philip Scheltens (Contributor)
- Wiesje M. van der Flier (Contributor)
- Andreas Nabers (Contributor)
- Charlotte E Teunissen (Contributor)
- Klaus Gerwert (Contributor)
Dataset